技術(shù)外包服務(wù):

★端粒酶逆轉(zhuǎn)錄酶抗體費(fèi)用 分子生物學(xué)：質(zhì)粒抽提、PCR、Q-PCR、RT-PCR、分子生物學(xué)：基因合成、引物合成、基因測(cè)序、載體構(gòu)建等

★蛋白工程：原核、哺乳動(dòng)物蛋白表達(dá)系統(tǒng)等

★病毒包裝：腺病毒、慢病毒等

★抗體工程：磁珠分選、病理染色、WB、ELISA、IP、IF、IHC、FACS、Confocal等等

★細(xì)胞工程：細(xì)胞表型分析(凋亡、增殖、周期、遷移、侵襲、修復(fù)、克隆形成)、細(xì)胞培養(yǎng)、細(xì)胞膜制備、穩(wěn)定細(xì)胞株構(gòu)建、細(xì)胞RNAi技術(shù)等等。

實(shí)驗(yàn)流程：

端粒酶逆轉(zhuǎn)錄酶抗體費(fèi)用 英文名稱  Anti-TERT

中文名稱  端粒酶逆轉(zhuǎn)錄酶抗體費(fèi)用 

別    名 EST2; hEST2; TCS1; Telomerase associated protein 2; Telomerase Catalytic Subunit; Telomere Reverse Transcriptase; Telomerase reverse transcriptase; TERT; TP2; TRT; TERT_HUMAN; Telomerase reverse transcriptase; HEST2; Telomerase catalytic subunit; Telomerase-associated protein 2.

產(chǎn)品屬性：

濃    度  1mg/1ml

規(guī) 格  0.1ml/100μg 0.2ml/200μg

抗體來源  Rabbit

克隆類型   polyclonal

交叉反應(yīng)   Human, Mouse, Rat

產(chǎn)品類型   一抗  

研究領(lǐng)域     細(xì)胞生物 免疫學(xué) 細(xì)胞凋亡 轉(zhuǎn)錄調(diào)節(jié)因子

蛋白分子量  predicted molecular weight: 124kDa 

性    狀   Lyophilized or Liquid

免 疫 原  KLH conjugated synthetic peptide derived from human TERT

亞    型  IgG

純化方法   affinity purified by Protein A

儲(chǔ) 存 液   0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide

端粒酶逆轉(zhuǎn)錄酶抗體費(fèi)用 產(chǎn)品應(yīng)用   WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500

（石蠟切片需做抗原修復(fù)） 

 not yet tested in other applications.

 optimal dilutions/concentrations should be determined by the end user.  

保存條件  Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. 

Important Note  This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. 

產(chǎn)品介紹 Telomerase is a ribonucleoprotein enzyme essential for the replication of chromosome termini in most eukaryotes. It elongates telomeres. It is a reverse transcriptase that adds simple sequence repeats to chromosome ends by copying a template sequence within the RNA component of the enzyme. Telomerase are large DNA-protein complexes with telomerase expression being the subject of recent research due to its link to cell immortalization. Recent evidence has shown that MYC upregulates the catalytic subunit of telomerase, TERT, and that Telomerase is a ribonucleoprotein polymerase that maintains telomere ends by addition of the telomere repeat TTAGGG. The enzyme consists of a protein component with reverse transcriptase activity, encoded by this gene, and an RNA component which serves as a template for the telomere repeat. Telomerase expression plays a role in cellular senescence, as it is normally repressed in postnatal somatic cells resulting in progressive shortening of telomeres. Deregulation of telomerase expression in somatic cells may be involved in oncogenesis. Studies in mouse suggest that telomerase also participates in chromosomal repair, since de novo synthesis of telomere repeats may occur at double-stranded breaks. Alternatively spliced variants encoding different isoforms of telomerase reverse transcriptase have been identified; the full-length sequence of some variants has not been determined. Alternative splicing at this locus is thought to be one mechanism of regulation of telomerase activity. [provided by RefSeq, Jul 2008].

Function : Telomerase is a ribonucleoprotein enzyme essential for the replication of chromosome termini in most eukaryotes. Active in progenitor and cancer cells. Inactive, or very low activity, in normal somatic cells. Catalytic component of the teleromerase holoenzyme complex whose main activity is the elongation of telomeres by acting as a reverse transcriptase that adds simple sequence repeats to chromosome ends by copying a template sequence within the RNA component of the enzyme. Catalyzes the RNA-dependent extension of 3'-chromosomal termini with the 6-nucleotide telomeric repeat unit, 5'-TTAGGG-3'. The catalytic cycle involves primer binding, primer extension and release of product once the template boundary has been reached or nascent product translocation followed by further extension. More active on substrates containing 2 or 3 telomeric repeats. Telomerase activity is regulated by a number of factors including telomerase complex-associated proteins, chaperones and polypeptide modifiers. Modulates Wnt signaling. Plays important roles in aging and antiapoptosis.

Subunit : Homodimer; dimerization is required to produce a functional complex. Oligomer; can form oligomers in the absence of the telomerase RNA template component (TERC). Catalytic subunit of the telomerase holoenzyme complex composed minimally of TERT and TERC. The telomerase complex is composed of TERT, DKC1, WDR79/TCAB1, NOP10, NHP2, GAR1, TEP1, EST1A, POT1 and a telomerase RNA template component (TERC). The molecular chaperone HSP90/P23 complex is required for correct assembly and stabilization of the active telomerase. Interacts directly with HSP90A and PTGES3. Interacts with HSPA1A; the interaction occurs in the absence of TERC and dissociates once the complex has formed. Interacts with RAN; the interaction promotes nuclear export of TERT. Interacts with XPO1. Interacts with PTPN11; the interaction retains TERT in the nucleus. Interacts with NCL (via RRM1 and C-terminal RRM4/Arg/Gly-rich domains); the interaction is important for nucleolar localization of TERT. Interacts with SMARCA4 (via the bromodomain); the interaction regulates Wnt-mediated signaling. Interacts with MCRS1 (isoform MCRS2); the interaction inhibits in vitro telomerase activity. Interacts with PIF1; the interaction has no effect on the elongation activity of TERT. Interacts with PML; the interaction recruits TERT to PML bodies and inhibits telomerase activity.

Subcellular Location : Nucleus, nucleolus. Nucleus, nucleoplasm. Nucleus. Chromosome, telomere. Cytoplasm. Nucleus, PML body. Note=Shuttling between nuclear and cytoplasm depends on cell cycle, phosphorylation states, transformation and DNA damage. Diffuse localization in the nucleoplasm. Enriched in nucleoli of certain cell types. Translocated to the cytoplasm via nuclear pores in a CRM1/RAN-dependent manner involving oxidative stress-mediated phosphorylation at Tyr-707. Dephosphorylation at this site by SHP2 retains TERT in the nucleus. Translocated to the nucleus by phosphorylation by AKT.

Tissue Specificity : Expressed at a high level in thymocyte subpopulations, at an intermediate level in tonsil T-lymphocytes, and at a low to undetectable level in peripheral blood T-lymphocytes.

Post-translational modifications : Ubiquitinated, leading to proteasomal degradation.

Phosphorylation at Tyr-707 under oxidative stress leads to translocation of TERT to the cytoplasm and reduces its antiapoptotic activity. Dephosphorylated by SHP2/PTPN11 leading to nuclear retention. Phosphorylation by the AKT pathway promotes nuclear location.

DISEASE : Note=Activation of telomerase has been implicated in cell immortalization and cancer cell pathogenesis.

Defects in TERT are associated with susceptibilty to aplastic anemia (AA) [MIM:609135]. AA is a rare disease in which the reduction of the circulating blood cells results from damage to the stem cell pool in bone marrow. In most patients, the stem cell lesion is caused by an autoimmune attack. T-lymphocytes, activated by an endogenous or exogenous, and most often unknown antigenic stimulus, secrete cytokines, including IFN-gamma, which would in turn be able to suppress hematopoiesis.

Note=Genetic variations in TERT are associated with coronary artery disease (CAD).

Defects in TERT are the cause of dyskeratosis congenital autosomal dominant type 2 (DKCA2) [MIM:613989]. A rare multisystem disorder caused by defective telomere maintenance. It is characterized by progressive bone marrow failure, and the clinical triad of reticulated skin hyperpigmentation, nail dystrophy, and mucosal leukoplakia. Common but variable features include premature graying, aplastic anemia, low platelets, osteoporosis, pulmonary fibrosis, and liver fibrosis among others. Early mortality is often associated with bone marrow failure, infections, fatal pulmonary complications, or malignancy.

Defects in TERT are the cause of dyskeratosis congenital autosomal recessive type 4 (DKCB4) [MIM:613989]. A rare multisystem disorder caused by defective telomere maintenance. It is characterized by progressive bone marrow failure, and the clinical triad of reticulated skin hyperpigmentation, nail dystrophy, and mucosal leukoplakia. Common but variable features include premature graying, aplastic anemia, low platelets, osteoporosis, pulmonary fibrosis, and liver fibrosis among others. Early mortality is often associated with bone marrow failure, infections, fatal pulmonary complications, or malignancy.

Defects in TERT are a cause of susceptibility to pulmonary fibrosis idiopathic (IPF) [MIM:178500]. Pulmonary fibrosis is a lung disease characterized by shortness of breath, radiographically evident diffuse pulmonary infiltrates, and varying degrees of inflammation and fibrosis on biopsy. It results in acute lung injury with subsequent scarring and endstage lung disease.

Similarity : Belongs to the reverse transcriptase family. Telomerase subfamily.

Contains 1 reverse transcriptase domain.

Database links :

UniProtKB/Swiss-Prot: O14746.1

Entrez Gene: 7078 Human

Entrez Gene: 21859 Mouse

Entrez Gene: 25358 Rat

Omim: 188826 Human

SwissProt: P35625 Human

SwissProt: P39876 Mouse

SwissProt: P48032 Rat

Unigene: 644633 Human

端粒酶逆轉(zhuǎn)錄酶hTERT是構(gòu)成端粒酶的組分之一，是端粒酶活性的必需和限速成分，水平?jīng)Q定細(xì)胞端粒酶的活性。抑制hTERT可降低端粒酶的活性，從而抑制瘤細(xì)胞生長。目前對(duì)hTERT的研究已成為端粒酶研究的熱點(diǎn)問題，已發(fā)現(xiàn)TERT蛋白表達(dá)在診斷中有重要意義，并制備了hTERT抗體及應(yīng)用核酶技術(shù)等來抑制hTERT蛋白的表達(dá)，抑制端粒酶活性，從而的生長。

端粒反轉(zhuǎn)錄酶又稱端粒酶催化亞單位 （hTRT；Telomerase catalytic subunit；HEST2；Telomerase-associated protein 2；TP2；Telomerase reverse transcriptase；telomerase catalytic subunit）是細(xì)胞永生化及發(fā)生過程中的端粒酶活化的主要限速步驟。hTRT基因表達(dá)可以反映端粒酶活性，與端粒酶活性具有平行關(guān)系。全、新、優(yōu)、品、好四大特點(diǎn)：

端粒酶逆轉(zhuǎn)錄酶抗體費(fèi)用 全：公司提供上萬種產(chǎn)品，涵蓋了生物試劑，elisa試劑盒，標(biāo)準(zhǔn)品，培養(yǎng)基，原裝耗材，抗體、培養(yǎng)基、ATCC細(xì)胞等，基本上各種科研所需產(chǎn)品在我司都能找到。

新：產(chǎn)品更新速度較快，基本上每周都有新產(chǎn)品出現(xiàn)。

優(yōu)：產(chǎn)品質(zhì)量好，投訴比較少。

好：我公司具有優(yōu)質(zhì)的技術(shù)團(tuán)隊(duì)，產(chǎn)品一旦售出，實(shí)驗(yàn)過程中遇到困難可提供在線技術(shù)咨詢。使您使用產(chǎn)品時(shí)沒有任何的后顧之憂。

正在熱銷的相關(guān)產(chǎn)品：

Tsg101(Tumor susceptibility gene 101 protein) Tsg101抗原Multi-class antibodies規(guī)格： 0.5mg

Anti-CTNNAL1 粘附分子相關(guān)蛋白a1抗體Multi-class antibodies規(guī)格： 0.1ml

Rhesus antibody Rh PDCD4 凋亡相關(guān)蛋白4抗體 規(guī)格 0.2ml

CSF1R Kit Human 人 CSF1R / MCSF Receptor / CD115 ELISA配對(duì)抗體 ELISA

TSARG2 英文名稱： 形成相關(guān)凋亡蛋白2抗體 0.2ml

Casein 英文名稱： 酪蛋白抗體 0.1ml

Anti-CTNNAL1 粘附分子相關(guān)蛋白a1抗體Multi-class antibodies規(guī)格： 0.1ml

NOS-2 peptide 合成酶-2多肽抗原Multi-class antibodies規(guī)格： 0.5mg

Anti-AQP2 水通道蛋白-2抗體Multi-class antibodies規(guī)格： 0.1ml

Rhesus antibody Rh phospho-ATG7(Ser95) 磷酸化自噬相關(guān)蛋白7抗體 規(guī)格 0.1ml

山羊抗人 IgM/HRP 0.1ml 美國Jackson公司分裝

Viperin 英文名稱： 病毒抑制蛋白Viperin抗體 0.2ml

Dio3 英文名稱： 甲狀腺素5'脫酶3抗體 0.1ml

Anti-AQP2 水通道蛋白-2抗體Multi-class antibodies規(guī)格： 0.1ml

Anti-SGK1/FITC 熒光素標(biāo)記糖皮質(zhì)激素調(diào)節(jié)激酶1抗體IgGMulti-class antibodies規(guī)格： 0.2ml

2,4-D/KLH(2,4-Dichlorophenoxyacetic acid) 2，4-二氯苯氧乙酸偶聯(lián)血藍(lán)蛋白Multi-class antibodies規(guī)格： 5mg

抗納曲酮抗體IgG anti-Natrexone 0.1ml

SGTA 英文名稱： 小谷酰胺三角四肽重復(fù)區(qū)蛋白α抗體 0.2ml

ERG3 英文名稱： 癌基因ERG3抗體 0.1ml

Rhesus antibody Rh phospho-PAK3(Ser139) 磷酸化p21激活激酶3抗體 規(guī)格 0.1ml

2,4-D/KLH(2,4-Dichlorophenoxyacetic acid) 2，4-二氯苯氧乙酸偶聯(lián)血藍(lán)蛋白Multi-class antibodies規(guī)格： 5mg

大鼠膜相關(guān)磷脂酶A2(PLA2G2A)ELISA試劑盒 ，英文名： PLA2G2A ELISA Kit

人6酮素(6-K-PG)ELISA檢測(cè)試劑盒Human6-keto-prostaglandin,6-K-PGELISAKit 96T/48T

羊環(huán)磷酸腺苷(cAMP)免疫試劑盒 Goat cyclic adenosine monophosphate,cAMP ELISA Kit

CLIAKitforPA-IgG/M/A(MouseplateletaibodiesIgG/M/A)ELISAKit小鼠抗血小板抗體IgG/M/A規(guī)格：48T/96T

水質(zhì)砷元素比色法定量檢測(cè)試劑盒20次

ELISAKitCIg人胞漿免疫球蛋白規(guī)格：48T/96T

大鼠腸堿性磷酸酶(ALPI)ELISA試劑盒 ，英文名： ALPI ELISA Kit

Rat compleme fragme 3A (C3a) ELISA Kit 大鼠補(bǔ)體片斷3a(C3a)ELISA試劑盒

Ratghcagons-likepepfide1,GLP-1ELISAKit 大鼠胰素樣肽1(Glp-1)ELISA試劑盒 96T/48T 進(jìn)口分裝

CLIAKitforcPLA2(RatCytosolicPhospholipaseA2,cPLA2)ELISAKit大鼠胞漿型磷脂酶A2規(guī)格：48T/96T

細(xì)胞樣品細(xì)胞色素C氧化酶表達(dá)免疫熒光檢測(cè)試劑盒10/20次

RatC-typenaiureticpeptide,CNPELISAKit大鼠C型尿肽(CNP)ELISA試劑盒規(guī)格：96T/48T

端粒酶逆轉(zhuǎn)錄酶抗體費(fèi)用 大鼠淀粉樣前體蛋白(βAPP)ELISA試劑盒 ，英文名： βAPP ELISA Kit

Porcine myelin basic protein (MBP) ELISA Kit 豬髓磷脂堿性蛋白(MBP)ELISA試劑盒

馬鈴薯特定基因序列(PATA)核酸檢測(cè)試劑盒(PCR-熒光探針法) 48T

CLIAKitforLTA(HumanlymphotoxinAlpha,LTA)ELISAKit人淋巴毒素α規(guī)格：48T/96T

通用96孔1塊

ELISAKitIrna雞免疫核糖核酸規(guī)格：48T/96T